Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2025 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to To the Point

To the Point

The Heart Disease Gene

Heart disease is America’s number one killer, and there hasn’t been a major new drug to fight it since statins came on the scene in the 1980’s. Now, researchers say, a single genetic mutation may lead the way to the next step forward.

  • rss
  • Share
By Warren Olney • Jun 20, 2014 • 1 min read

Heart disease is America’s number one killer, and there hasn’t been a major new drug to fight it since statins came on the scene in the 1980’s. Now, researchers say, a single genetic mutation may lead the way to the next step forward.

720,000 Americans have suffered heart attacks. But, in the future, they might be prevented if drugs are developed to mimic the mutation of a single gene. That’s according to today’s New England Journal of Medicine, which reports on research conducted by Dr. Sekar Kathiresan, Director of Preventive Cardiology at Massachusetts General Hospital and associate member of the Broad Institute.

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Warren Olney

    former KCRW broadcaster

  • KCRW placeholder

    Sekar Kathiresan

    Massachusetts General Hospital

    NewsNationalPolitics
Back to To the Point